Skip to main content
OpenTrials

Clinical trial condition

Heart Defects, Congenital

Explore clinical trials studying Heart Defects, Congenital. Study availability and eligibility vary by location and protocol.

805 public trials 179 recruiting studies
Refine in advanced search Browse all conditions

Heart Defects, Congenital trial results

Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

NCT03821129

Conditions
Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +13 more
Locations
  • St. Mary's Hospital Tucson, Arizona, United States
  • Scripps Health La Jolla La Jolla, California, United States
  • Loma Linda University Health Loma Linda, California, United States
  • University of California - San Francisco San Francisco, California, United States
View all 45 locations
View Trial Details
Recruiting

Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

NCT05264753

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +5 more
Locations
  • CHU Sainte-Justine Montreal, Canada
  • CHU de Lille - Institut Cœur-Poumon Lille, France
  • Hôpital Mère Enfant, CHU de Nantes Nantes, France
  • Ospedale Pediatrico Bambino Gesù Roma, Italy
View all 15 locations
View Trial Details
Recruiting

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

NCT07221851

Conditions
Bone Diseases, Bone Diseases, Developmental, Cardiovascular Abnormalities, +32 more
Locations
  • Ascendis Pharma Investigational Site Palo Alto, California, United States
  • Ascendis Pharma Investigational Site Sacramento, California, United States
  • Ascendis Pharma Investigational Site Aurora, Colorado, United States
  • Ascendis Pharma Investigational Site Centennial, Colorado, United States
View all 34 locations
View Trial Details
Recruiting

Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study

NCT07172464

Conditions
Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +18 more
Locations
  • UCLA Los Angeles, California, United States
  • The Cardiac and Vascular Institute Gainsville, Florida, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • Columbia University Medical Center/ NewYork Presbyterian Hospital New York, United States
View Trial Details
Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

NCT06081348

Conditions
22Q11 Deletion, 22q11 Deletion Syndrome, ADHD, +59 more
Locations
  • Alberta Children's Hospital - University of Calgary Calgary, Alberta, Canada
  • University of Alberta-Glenrose Edmonton, Alberta, Canada
  • Dalhousie University - IWK Health Centre Halifax, Nova Scotia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Recruiting

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

NCT02744677

Conditions
Aortic Valve Disease, Aortopulmonary Septal Defect, Cardiovascular Abnormalities, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California,, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations
View Trial Details

Related conditions